Use of Panax Quinquefolius and Acetylcarnitine Supplement (FORT UP®) Against Fatigue in Cancer Patients Admitted to Hospice Palliative Care

Use of Panax Quinquefolius and Acetylcarnitine Supplement (FORT UP®) Against Fatigue in Cancer Patients Admitted to Hospice Palliative Care

Download Citation in txt Download Citation in bib Download Citation in ris

Author Info

Corresponding Author
Massimo Bonucci
Department of Outpatient Oncology, Villa Benedetta Hospital, Rome, Italy

A B S T R A C T

For cancer patients, fatigue is one of the most frequent and disabling symptoms. Fatigue is a mix of symptoms like muscle pain, mental cognitive dysfunction, neurological disorders that make the patient completely inactive and into a state of complete abandonment. At this time not exist anything for treatment and today there is no specific guideline; only a very few substances can alleviate this situation. In our study, we’ve used two scales of VAS to better deeply understand the severity of symptoms. For treatment, we used a supplement (Fort up® - Gamfarma Italy) made with two active principles, Panax quinquefolium and acetyl-carnitine, in 56 cancer patients admitted to hospice palliative care, administered for three weeks to assess the effect in medium to severe asthenia. Both active principles have demonstrated activity in clinical studies against cancer-related fatigue with tonic and energizing action. At the end of study 46 out of 56 patients (82%) had an improvement of symptoms and in 18 patients (4 in low, 11 in medium and 3 in severe asthenia) (32%) these symptoms there resolved. The study aimed was to investigate the efficacy of this product on cancer-related fatigue in patients admitted to hospital palliative care. Our study demonstrated that this product can relieve cancer-related fatigue in this setting of cancer patients.

Article Info

Article Type
Research Article
Publication history
Received: Thu 09, Apr 2020
Accepted: Wed 22, Apr 2020
Published: Thu 30, Apr 2020
Copyright
© 2023 Massimo Bonucci. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.COR.2020.04.10